Поиск по каталогу |
(строгое соответствие)
|
- Профессиональная
- Научно-популярная
- Художественная
- Публицистика
- Детская
- Искусство
- Хобби, семья, дом
- Спорт
- Путеводители
- Блокноты, тетради, открытки
QSAR Study of Potent Gsk-3? Inhibitor for Type II Diabetes. Chemometric analysis based methods for new therapeutic application
В наличии
Местонахождение: Алматы | Состояние экземпляра: новый |
Бумажная
версия
версия
Автор: Pooja Mishra and Seema Kesar
ISBN: 9783330040434
Год издания: 2017
Формат книги: 60×90/16 (145×215 мм)
Количество страниц: 64
Издательство: LAP LAMBERT Academic Publishing
Цена: 21414 тг
Положить в корзину
Способы доставки в город Алматы * комплектация (срок до отгрузки) не более 2 рабочих дней |
Самовывоз из города Алматы (пункты самовывоза партнёра CDEK) |
Курьерская доставка CDEK из города Москва |
Доставка Почтой России из города Москва |
Аннотация: This is a best book for analyzing 2D QSAR technique for determining the potent GSK-3beta inhibitor against diabetes.Computer-aided drug design is a branch of medicinal/computational chemistry and is of great interest now a day. Computer-aided design of chemical compounds with controlled properties is generally performed using computer-aided design systems.Its becoming increasingly involved in understanding the differences between potent molecules and drug candidates (ADMET-absorption, distribution, metabolism, excretion and toxicity) this is already fueling a rise in impact and expectations for CADD. The use of quantitative structure-activity relationships (QSAR) has become increasingly helpful in understanding many aspects of chemical-biological interactions in drug and other scientific research. In the present effort, we exaggerate our pursuit of being establishing the relationship between the various physiochemical parameters and anti-diabetic activity of 3-aryl- 4-(arylhydrazono)-1H pyrazol-5-ones derivatives by using classical quantitative structure– activity relationship (QSAR) descriptors and similarity indices.
Ключевые слова: MLR, PLS, QSAR, 3-Aryl- 4(arylhydrazono)-1H pyrazol-5-ones derivatives, TSAR, FFNN, Similarity indices